Shares in medical tech company ResApp Health plummeted 77 per cent today on disappointing results of a clinical study on its ResAppDx technology.
09/08/2017 - 15:41
ResApp crashes on study results
09/08/2017 - 15:41
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)